ACTU
Actuate Therapeutics, Inc. Common stock
ACTU
ACTU
37 hedge funds and large institutions have $68.5M invested in Actuate Therapeutics, Inc. Common stock in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 7 closing their positions.
Holders
37
Holders Change
+12
Holders Change %
+48%
% of All Funds
0.5%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
12
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.62M |
| 2 |
2
BlackRock
New York
|
$1.19M |
| 3 |
VC
3
Voss Capital
Houston,
Texas
|
$1.75M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$721K |
| 5 |
BCM
5
BIOS Capital Management
Fort Worth,
Texas
|
$60.9M |
